a

Global Spinal Devices and Biologics Market to Grow 6.9% Annually Featured

Written by  Jaimie Oh | August 02, 2012
Social sharing
The global spinal device and biologics market is expected to grow at a compound annual growth rate of 6.9 percent until 2015, according to the latest analysis by Reporterlink.
One of the key factors contributing to this market growth is the development of better and longer-lasting implants. The market has also been witnessing an increase in the number of strategic alliances. However, the shortage of healthcare workers and high wages could pose a challenge to the growth of this market.

Companies dominating this market include DePuy, Medtronic, Stryker and Synthes.

More Articles on Devices:

Spinal Elements Launches Ti-Bond

Exactech Announces 2Q Revenue of $55.2M, Up 7%

DJO Global 2Q Net Sales Reach $286M, a 2.9% Increase
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.

blog comments powered by Disqus